Background: Interstitial lung disease (ILD) is the major cause of morbidity and mortality in patients with various rheumatic diseases. However, more interventions need to be sought. Tripterine, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback